A pharmaceutical containing a radionuclide, with uptake and clearance chosen for imaging or treatment. Biological targeting and radioactive decay jointly determine its useful signal and tissue dose.
An iodine radionuclide with approximately eight-day half-life, emitting beta particles and gamma rays. Its uptake and retention depend strongly on the carrier and tissue physiology.
Radioiodide used in selected thyroid treatments because iodine uptake localizes activity in thyroid tissue. Iodine-131 supplies local beta radiation and imageable gamma emission.
A diagnostic bone tracer combining technetium-99m with a diphosphonate carrier. Uptake reflects bone turnover and delivery, rather than a unique disease diagnosis.
A metastable nuclear isomer used in diagnostic tracers, with approximately six-hour half-life and imageable gamma rays. Its chemical carrier determines biological uptake.
Articles by others on the same topic
Radiopharmaceuticals are specialized drugs that contain radioactive isotopes and are used primarily in medical imaging and therapy. They are designed for diagnostic and therapeutic purposes, particularly in nuclear medicine. ### Key characteristics: 1. **Radioactive Isotopes**: Radiopharmaceuticals consist of a radionuclide (radioactive isotope) attached to a pharmaceutical component, which can target specific organs, tissues, or cellular receptors in the body.